CDKN2a/p16 Antagonizes Hepatic Stellate Cell Activation and Liver Fibrosis by Modulating ROS Levels
Open Access
- 24 March 2020
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Cell and Developmental Biology
- Vol. 8, 176
Abstract
The lipid-storage hepatic stellate cells (HSC) play as pivotal role in liver fibrosis being able to trans-differentiate into myofibroblasts in response to various pro-fibrogenic stimuli. In the present study we investigated the role of CDKN2a/p16, a negative regulator of cell cycling, in HSC activation and the underlying mechanism. Levels of p16 were significantly down-regulated in activated HSCs isolated from mice induced to develop liver fibrosis compared to quiescent HSCs isolated from the control mice ex vivo. There was a similar decrease in p16 expression in cultured HSCs undergoing spontaneous activation or exposed to TGF-β treatment in vitro. More important, p16 down-regulation was observed to correlate with cirrhosis in humans. In a classic model of carbon tetrachloride (CCl4) induced liver fibrosis, fibrogenesis was far more extensive in mice with p16 deficiency (KO) than the wild type (WT) littermates. Depletion of p16 in cultured HSCs promoted the synthesis of extracellular matrix (ECM) proteins. Mechanistically, p16 deficiency accelerated reactive oxygen species (ROS) generation in HSCs likely through the p38 MAPK signaling. P38 inhibition or ROS cleansing attenuated ECM production in p16 deficient HSCs. Taken together, our data unveil a previously unappreciated role for p16 in the regulation of HSC activation. Screening for small-molecule compounds that can boost p16 activity may yield novel therapeutic strategies against liver fibrosis.Keywords
This publication has 74 references indexed in Scilit:
- Cellular senescence and tumor suppressor gene p16International Journal of Cancer, 2011
- Control of the senescence-associated secretory phenotype by NF-κB promotes senescence and enhances chemosensitivityGenes & Development, 2011
- The nicotinamide adenine dinucleotide phosphate oxidase (NOX) homologues NOX1 and NOX2/gp91phox mediate hepatic fibrosis in miceHepatology, 2011
- Mitogen-Activated Protein Kinases and Reactive Oxygen Species: How Can ROS Activate MAPK Pathways?Journal of Signal Transduction, 2011
- NF-κB in the liver—linking injury, fibrosis and hepatocellular carcinomaNature Reviews Gastroenterology & Hepatology, 2011
- The p16INK4A tumor suppressor regulates cellular oxidative stressOncogene, 2010
- Modulation of Hepatic Fibrosis by c-Jun-N-Terminal Kinase InhibitionGastroenterology, 2010
- Redox Control of the Cell Cycle in Health and DiseaseAntioxidants & Redox Signaling, 2009
- The Nrf2 transcription factor protects from toxin-induced liver injury and fibrosisLaboratory Investigation, 2008
- PDGF essentially links TGF-β signaling to nuclear β-catenin accumulation in hepatocellular carcinoma progressionOncogene, 2006